Variable | No. (%) |
---|---|
Sociodemographic variables | |
Gender | |
Female* | 74 (84%) |
Male* | 14 (16%) |
Age, mean (SD)* | 32.48 (11.62) |
Household structure | |
Married* | 14 (16%) |
Have children* | 33 (38%) |
Level of education | |
Primary school* | 11 (12%) |
Secondary school* | 50 (57%) |
University degree* | 26 (30%) |
Doctorate | 1 (1%) |
Occupational status | |
Working* | 49 (56%) |
Student* | 22 (25%) |
Unemployed* | 13 (15%) |
Disability pension | 1 (1%) |
Retired | 3 (3%) |
Clinical variables | |
Years with BDD, mean (SD)* | 18.83 (13.27) |
Insight | |
Good* | 46 (52%) |
Poor* | 34 (39%) |
Delusional* | 8 (9%) |
No. body areas of concern, mean (SD) | 7.67 (4.68) |
Comorbidity | |
Current depressive episode* | 44 (50%) |
Panic disorder | 3 (3%) |
Social anxiety disorder* | 25 (28%) |
Obsessive-compulsive disorder* | 8 (9%) |
Generalized anxiety disorder* | 15 (17%) |
Bulimia nervosa | 9 (10%) |
ADHD | 2 (2%) |
Medication | |
SSRI* | 12 (14%) |
SNRI | 2 (2%) |
Other antidepressant* | 7 (8%) |
Previous treatment | |
Cognitive behavioral therapy for BDD* | 10 (11%) |
Other psychological treatment* | 53 (60%) |
Previous contact with psychiatry* | 54 (61%) |
Plastic surgery* | 21 (24%) |
No. of plastic surgeries, mean (SD)* | 0.56 (1.30) |
Baseline measurements | |
CGI-Severity | |
2 - Borderline mentally ill | 3 (3%) |
3 - Mildly ill* | 13 (15%) |
4 - Moderately ill* | 47 (53%) |
5 - Markedly ill* | 21 (24%) |
6 - Severely ill | 3 (3%) |
7 - Among the most extremely ill patients | 1 (1%) |
GAF, mean (SD)* | 56.24 (6.67) |
BDD-YBOCS, mean (SD)* | 27.74 (5.52) |
EQ-5D, mean (SD)* | 13.06 (3.55) |
MADRS-S, mean (SD)* | 18.92 (9.05) |
Treatment-related variables | |
Treatment credibility, mean (SD)* | 31.59 (11.51) |
Working alliance inventory, mean (SD)* | 65.27 (13.15) |
No. modules completed, mean (SD)* | 6.25 (2.45) |
Time spent on treatment (per week) | |
1 h* | 16 (18%) |
2 h* | 17 (19%) |
3 h* | 15 (17%) |
4 h* | 6 (7%) |
5 h* | 6 (7%) |
6 h* | 8 (9%) |
7 h | 3 (3%) |
8 h | 5 (6%) |
9 h or more* | 12 (14%) |
Outcome: Number of participants in remission | |
Post treatment | 27 (31%) |
3-month follow-up | 37 (42%) |
12-month follow-up | 41 (47%) |
24-month follow-up | 53 (60%) |